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People with learning disabilities often have seizures in addition to other disorders. Precise diagnosis may be difficult, 
but accuracy can be improved using electroencephalographic and video investigations. Following the establishment of a 
diagnosis of epilepsy, individually tailored care is necessary taking into account other health, behavioural and therapeutic 
issues. Neuroimaging may indicate a need for surgery which should not be automatically excluded as a treatment option. 
Rational antiepileptic drug use is advised, with emphasis upon the newer agents due to their better tolerance and ease of 
use. A programme of regular review will prevent over-medicating. Drug therapy may be withdrawn in a seizure-free patient. 
Realistic goals should be established for each individual coupled with an optimistic approach to care. However, future 
developments require a solid evidence base combined with rationality in all aspects of management. The community learning 
disability epilepsy nurse specialist is the key health-care professional who can ensure that a learning disabled individual with 
epilepsy is able to take full advantage of all available services. Education, closer collaboration and the mutual recognition 
of skills will ensure more cohesive and comprehensive care for this disadvantaged patient population. 
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INTRODUCTION 
The recent sad deaths of Diana, Princess of Wales 
and Mother Theresa of Calcutta have drawn hearts 
and minds to the needs of people and causes that are 
frequently shunned. In the world of epilepsy, it is of- 
ten the patient with learning disabilities who falls into 
this category despite the work of the dedicated indi- 
viduals involved in their care. This multiply disadvan- 
taged group are often regarded with a sense of despair 
as diagnosis can be difficult and treatment ineffective. 
However, the redefinition of aims and objectives and 
the realization that ‘seizure-free’ should not be the 
only goal will allow the adoption of a more liberated 
and positive attitude to this patient population. 
In the past, people with learning disabilities have 
been regarded financially as ‘major burden[s] on the 
National Health Service’. However the use of a ra- 
tional approach to care allows clearer justification of 
expenditure and may gradually prise away this unfor- 
tunate title. The aims of high-quality care for people 
with epilepsy and learning disabilities are the same 
as those for epilepsy alone: increased quality of life 
adjusted years and more effective, efficient use of 
resources2. Those involved in the therapeutic pathway 
are not just health professionals but also families, car- 
ers, social service, employment and educational agen- 
cies, and people in the voluntary sector3. Developing 
close links between all of these contributors provides 
the best opportunity for optimal management. 
EPIDEMIOLOGY 
An average general practitioner with a list of 2000 
has 36-38 patients with learning disabilities, of whom 
about six will have severe learning disabilities4,5. 
Epilepsy has a lifetime prevalence of 2-5% of the 
population. Thus, the same general practitioner will 
have approximately lo-15 epileptic patients on ac- 
tive treatment and another 15-25 with a history of 
seizures but not currently receiving treatment.‘. An 
average general practitioner will see only one or two 
new cases of epilepsy each yearc. In general terms, 
the prevalence of epilepsy is high is childhood and 
adolescence, is stable in the adult years, and in- 
creases again in the elderly7. In contrast, the preva- 
lence of epilepsy in patients with learning disabilities 
decreases from the age of 50 years’. 
The common coexistence of epilepsy and learning 
disabilities has been the subject of studies that have 
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used a variety of epidemiological methods and defi- 
nitions. Goulden et al.” and Sillanpaa’” have raised 
concerns regarding the interpretation of results as they 
can be significantly different depending on the study 
design. Following his review of existing studies, Sil- 
lanpaa” gave an overall prevalence of epilepsy of 
15% in people with mild learning disabilities (IQ > 
50) and 30% in those with severe learning disabili- 
ties (IQ < 50). He recommended the use of the un- 
selected prospective cohort study as the best method 
of examining life-time prevalence or preferably cu- 
mulative incidence of epilepsy in this clinical setting. 
People with mild learning disabilities (IQ 50-70) and 
no other concomitant conditions are at the lowest risk 
(5-7%) of developing epilepsy’, ’ ’ . In contrast up to 
75% of those with additional disabilities such as cere- 
bral palsy or a postnatal brain injury have epilepsy. 
In addition, severe learning disability is more likely 
in patients with early seizure onset and less likely if 
there are only partial seizures12. 
Learning disabilities and epilepsy commonly co- 
exist in certain chromosomal or dysplastic condi- 
tions such as Down syndrome. Approximately 8-10% 
of this population have a history of seizures13-15, 
the distribution of which occurs in a bimodal pat- 
tern. Infantile spasms contribute to the first peak al- 
though this has a relatively benign outcome in Down 
syndrome I33 I63 17. The second peak occurs in the 
oldest age groupsI and is believed to be associ- 
ated with the dementing process’4* “. Interestingly, 
seizure control is generally straightforward’3* ‘& I7 
particularly if linked to early onset and the presence 
of one seizure type . I8 This promotes the hypothe- 
sis that mechanisms exist in Down syndrome which 
limit seizure generation or spread, the clarification of 
which could be of more general significance”. 
The neurocutaneous syndromes, such as the Sturge- 
Weber syndrome and tuberous sclerosis, can also be 
associated with learning disabilities and epilepsy, al- 
though this is not always the case20-22. Everyone 
with learning disabilities and tuberous sclerosis in 
the study by Webb and colleagues22 had epilepsy. 
The authors stressed that tuberous sclerosis does not 
cause learning disabilities in the absence of seizures, 
and learning disability is rare if seizures do not oc- 
cur in the first few years of life. Other syndromes 
most recently highlighted due to their association 
with epilepsy include the congenital bilateral perisyl- 
vian syndrome23-25, the Aicardi syndrome26, and the 
northern epilepsy syndrome27-29. 
MORTALITY 
The life expectancy of people with learning disabili- 
ties is lower than that in the general population3’ with 
the probability of survival decreasing as the sever- 
ity of learning disability increases”‘. The death rate 
for patients with mild to moderate learning disabili- 
ties is around twice that of the general population. 
while those with severe and profound levels have 
rates 7 and 31 times respectively those of the gen- 
eral population”. Individuals with a higher function- 
ing ability have a longer life expectancy32, and those 
who survive beyond the age of 50 have fewer health 
problems than do younger age groups33. Eyman and 
co-workers34 found the poorest outlook in patients 
with severe disabilities who were non-mobile and re- 
quired to be tube-fed by other people. Approximately 
50% died within a 5-year follow-up period. 
People with epilepsy are reported to have a higher 
mortality rate than the general population, especially 
in the first 10 years following diagnosis35,36. Partic- 
ular attention has been drawn to sudden unexpected 
death in association with epilepsy37-39 including in 
patients with learning disabilities4’. The coexistence 
of learning disabilities and epilepsy results in a further 
rise in mortality rate30-32,4’A3. Forsgren et ~1.~~ fol- 
lowed a complete cohort known to have learning dis- 
abilities in a Swedish province over a 7-year period. 
During this time 8.4% of the 1478 patients died. The 
standardized mortality ratio was significantly greater 
than that of the general population of 1.6, but was fur- 
ther raised at 5.0 for patients with learning disabilities 
and epilepsy, and 5.8 for those who, in addition, had 
cerebral palsy. Mortality rose with increasing seizure 
frequency in the preceding year, and was highest in 
patients with primary generalized seizures. 
The leading cause of death in people with learning 
disabilities is pneumonia30,31, and this is also true 
for those who have epilepsy4’A3. In some instances 
death was directly attributable to the epilepsy42. For 
example, Forsgren et ~1.~~ reported that a seizure was 
the probable cause of death in 6.7% in their study 
group. Nashef et al. 4o found that most sudden deaths 
in their study population were unwitnessed and all 
occurred when the pupils under study were not under 
close supervision at their special school. 
DIAGNOSIS 
The diagnosis of epilepsy relies heavily upon an ac- 
curate description of events and the presence of a wit- 
ness. Due to limitations in communicatior? and the 
wide differential diagnosis lo, diagnosing epilepsy and 
classifying syndromes in patients with learning dis- 
abilities can be very difficult45,46. The individual is 
often unable to describe the symptoms and sensations, 
which are experienced during an aura or postictally”. 
Professional carers attending a clinic with such a pa- 
tient often vary, and there may be a lack of continu- 
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ity in information sharing. All this adds to the unease 
about the accuracy of diagnosis compared to other 
patient groups. 
The most common seizure type in people with 
learning disabilities is the generalized tonic-clonic 
seizure. These were found in 87.3% of an institution- 
alized group4’ and in 68.2% of a population-based 
group of learning disabled people with epilepsy8. 
Steffenburg et al. I2 carried out a population-based 
study of learning disabled children. Of those studied 
20.4% had partial seizures only, 60.2% generalized 
seizures only, and 19.4% had mixed partial and gen- 
eralized seizures. Accuracy of classification is limited 
by communication abilities. In particular, the preva- 
lence of partial seizures may be underestimated”. 
Accuracy of diagnosis can also be affected by the 
presence of behavioural problems in approximately 
55% of people with learning disabilities48. Deb and 
Hunter48 found that patie nts with mild degrees of 
learning disabilities, multiple seizure types, frequent 
seizures and generalized epileptiform activity on the 
electroencephalograph (EEG), had more problem be- 
haviour than similarly affected people who did not 
have epilepsy. Severe learning disabilities and slow- 
wave EEG activity, paradoxically, was associated 
with less problem behaviour than in non-epileptics. 
Maladaptive behaviour was one specific area of study 
but much of this could be due to or related to epilep- 
tiform activity. Gedye has proposed that extreme 
self-injury49 episodic rage, aggression5’ and stereo- 
typic movements5’ . m patients with learning disabili- 
ties could be due to seizure phenomena. Involuntary 
movements, such as orofacial dyskinaesia, may be 
a consequence of treatment with neuroleptic drugs52 
but could also be due to seizure activity. 
In approaching this potentially diagnostic minefield 
in any learning disabled individual with suspected 
epilepsy, the standard method of history taking should 
be used to gain a full description of possible seizure 
events. This includes any precipitating factors, a de- 
scription of what occurred during the prodromal pe- 
riod, the ‘seizure’ itself and the aftermath. Codes can 
be used by carers and individuals to simplify sub- 
sequent event recording. The past medical history 
should include details about any aetiological factors 
for the learning disability and for the epilepsy, in- 
cluding genetic or metabolic disorders, birth trauma, 
febrile convulsions, and family history of epilepsy or 
learning disability. A social and psychological eval- 
uation including a measurement of IQ (unless al- 
ready known) should be carried out. Physical exam- 
ination should incorporate an assessment of the dis- 
abilities and the effects of injury, nutritional status 
and drug side-effects5’. It may be possible to classify 
seizure type(s) and epileptic syndrome at this early 
stage using the International League Against Epilepsy 
criteria45, but often further time and investigation are 
required. 
INVESTIGATION 
Routine and ambulatory electroencephalography, 
sometimes with synchronous video recording, are 
used to help differentiate between seizure activity and 
behavioural disorders46,54. EEG-video techniques, 
however, may not be widely available and, if long- 
term monitoring is used, the cost is high and the pro- 
cedure can be frustrating for patients and carers alike. 
Antiepileptic drug dose reduction methods have been 
examined as a way of increasing the likelihood of 
capturing a seizure or event occurrence during a mon- 
itored period5”. Concern has been raised about how 
well people with learning disabilities tolerate EEGs 
and, in particular, long-term monitoring. Reassurance 
about the level of technical success and benefit to pa- 
tients has been offered by both Lannon’” and Holmes 
et ~1.‘~. Carers too value EEG and video recording as 
it can help them respond appropriately to particular 
patterns of behaviour5”. However, Brodtkorbb7 was 
only able to obtain EEGs from 53 out of 63 institu- 
tionalized learning disabled individuals due to ‘coop- 
eration problems’. 
A learning disabled individual with a presumed 
psychiatric problem may be found using EEG tech- 
niques to have a seizure disorder such as non- 
convulsive status epilepticus. This may present with 
insidious or paroxysmal change in neurovegetative. 
behavioural, cognitive or affective symptomss7. Non- 
convulsive status may be under-diagnosed in people 
with learning disabilities and the symptoms can result 
in inappropriate treatment if they are of a predomi- 
nantly psychiatric nature. It has also been reported 
that benzodiazepines can be ineffective in treating 
non-convulsive status and, if used excessively, can 
even precipitate recurrent episodess8. 
A variety of guidelines are available to help dif- 
ferentiate nonepileptiform or psychogenic episodes 
from epileptic seizures lo. 54. “. Although this process 
can be made easier using EEG-video recording, such 
techniques may not pick up all of the seizures”. Bin- 
nie and Prio@O, therefore, recommended that interpre- 
tation of an apparently negative ictal EEG depended 
‘on the nature of the seizure and co-registration of the 
EEG and behaviour to facilitate detection of minimal 
EEG changes’. 
Neuroimaging is used when seizures appear to have 
a focal onset to identify any causative abnormality. 
Difficulties in obtaining accurate seizure histories for 
people with learning disabilities may result in a high 
proportion being referred for neuroimaging. Sedation 
may be necessary due to the nature and duration 
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of the investigation. Computer-assisted tomography 
(CT) scans are best able to identify gross structural 
pathology, while magnetic resonance imaging (MRI) 
is now regarded as the neuroimaging technique of 
choice due to its high sensitivity61. Magnetic reso- 
nance imagery allows a more accurate correlation of 
epileptogenic foci and brain lesions and, thus, aids de- 
cisions about possible surgical treatment20g62,63. Un- 
fortunately, there is limited access to MRI in some 
areas due to availability and financial restrictions. A 
variety of other scanning techniques are possible in 
some centres such as functional MRI, single pho- 
ton emission computed tomography (SPECT), mag- 
netic resonance spectroscopy, and positron emission 
tomography (PET). 
ANTIEPILEPTIC DRUG THERAPY 
For many years now the previously pessimistic views 
on prognosis for people with learning disabilities and 
epilepsy, including a reluctance for trials off treat- 
ment even if seizure free, have been discouraged. 
This is not to say that these individuals do not have 
refractory seizures, concomitant conditions, and re- 
quire polypharmacy. They are, as Mattson46 states, 
‘unique management challenges’. However, manage- 
ment plans should be in keeping with the findings 
of many studies supporting the beneficial effects of 
simplification of antiepileptic drug regimens, reduc- 
ing polypharmacy, and, where possible, discontinuing 
treatment in a seizure-free patient64-72. 
The current pharmacological treatment of epilepsy 
raises particular concerns regarding side-effects, a 
limit to increasing efficacy with polypharmacy, and 
pharmacokinetic and pharmocodynamic drug interac- 
tions. Monotherapy is advocated whenever possible 
at a dose which results in plasma drug levels within 
a target range but without unacceptable side-effects73. 
In practical terms, however, regular plasma drug- 
level monitoring is not always desirable. Where drugs 
are used in combination, a ‘rational’ approach has 
been suggested using the fewest possible antiepilep- 
tic drugs at the lowest effective doses74,75. Pharma- 
cological intervention in patients with learning dis- 
abilities and epilepsy should be used in parallel with 
nonpharmocoligical measures such as environmental 
and personal support. 
A balance must often be struck in treating epilepsy 
in patients with learning disabilities due to the pres- 
ence of concomitant conditions and drug side-effects. 
The use of multiple antiepileptic drugs can have detri- 
mental effects on psychosocial functioning indepen- 
dent of seizure frequency76 and result in sedation, 
cognitive deficits and psychomotor impairment69,77. 
Families or carers may recommend the compromise 
of an increased number of seizures rather than look- 
ing after an individual who is heavily sedated due to 
anticonvulsant toxicity. Such views should be highly 
respected. 
Few therapeutic assessments have been carried out 
in learning disabled patients, and there is a conspic- 
uous dearth of placebo-controlled double-blind trials 
in this population. In clinical practice, there should 
be a high index of suspicion regarding potential side 
effects of AEDs. The individual may be unable to ex- 
press what he or she feels is wrong, and so a change 
in mood or behaviour may be all that is apparent 
when drug toxicity exists. Concern about the side- 
effects of phenobarbital is so strong that it is now 
being increasingly replaced by less sedating drugs7’. 
Valproate may be the drug of choice in many in- 
stances due to is wide range of efficacy, but it is 
teratogenic and often causes weight gain, the latter 
a problem already present in many learning disabled 
individuals. There appears to be a move towards the 
newer generation of anticonvulsants although solid 
evidence in support of their superiority over estab- 
lished drugs is lacking. The argument is that they 
appear as effective as the older drugs, but are better 
tolerated and less sedating. In addition, they do not 
require plasma level monitoring, cause fewer drug in- 
teractions and, for some at least, there is no evidence 
so far of teratogenicity78,79. The issues of contracep- 
tion and pregnancy should not be overlooked in the 
learning disabled population as they may be sexually 
active. 
Lamotrigine should be regarded as a particularly 
useful antiepileptic drug in patients with learning dis- 
abilities as it may not only improve seizure con- 
trol but also mental state80,81. Buchanan82 found 
that 74% of his study group showed a greater than 
50% improvement in seizure control with 35% be- 
coming seizure-free. Sixty-five per cent had an en- 
hanced quality of life, as assessed by improved alert- 
ness, mobility, speech and independence. Lamotrig- 
ine has also proved efficacious in the treatment of 
Rett syndromeg3 and Lennox-Gastaut syndrome84, 85. 
Uvebrant and Bauzienesl reported improved seizure 
control in 63% and 38% of individuals with infantile 
spasms and Lennox-Gastaut syndrome respectively. 
Starting lamotrigine at low doses with an initial slow 
titration minimizes the risk of the potentially serious 
side-effect of a rash86. 
Vigabatrin has also been studied in patients with 
learning disabilities and epilepsy87-91. It reduced 
seizures by at least 50% in 42% of 36 patients 
with learning disabilities, with a gradual reduction 
to 22% of patients after 5 years follow-up89s90. Top- 
iramate is being used cautiously but optimistically in 
people with learning disabilities. It is also effective 
in treating seizures in patients with Lennox-Gastaut 
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syndrome92, with the best response being noted for 
tonic-clonic seizures, followed by tonic, atonic, ab- 
sence and myoclonic seizures’“. However, like the 
majority of the newest anticonvulsant drugs, topira- 
mate has been linked with behavioural and psychiatric 
problems. Similarly, gabapentin has been associated 
with hypomania and behavioural changes in people 
with learning disabilities94-96. 
Learning disabled individuals often require both 
antiepileptic and antipsychotic medication. Clarke et 
al.“’ found that up to 40.2%, 19.3% and 10.1% of 
people with learning disabilities in hospital, commu- 
nity and family homes respectively were taking major 
tranquillizers. Similarly, 26.2%, 9.3% and 18.5% took 
anticonvulsants. Reassuringly, despite the fact that 
high doses of antipsychotics may provoke seizures, 
small to moderate amounts do not carry the same 
level of concem7’. The Royal College of Psychia- 
trists’ Consensus Pane19s produced guidelines on the 
use of high doses of antipsychotic drugs, identify- 
ing in particular the difficulties in prescribing these 
drugs for patients with learning disabilities due to the 
frequent coexistence of epilepsy. Deb and Fraser99 
advise a ‘common-sense rational approach’ to their 
use. 
In the Epilepsy Unit at the Western Infir- 
mary in Glasgow, the broad-spectrum antiepilep- 
tic drugs sodium valproate, lamotrigine and topi- 
ramate are used singly and in combination, par- 
ticularly frequently in patients with learning dis- 
abilities who often have multiple-seizure types and 
difficult-to-control epilepsy”‘. Withdrawing enzyme- 
inducers, such as carbamazepine and phenytoin, 
makes antiepileptic (and other) drug therapy easier 
to manage. The cautious removal of barbiturates and 
benzodiazepines may improve problem behaviour. 
The end-point may not necessarily be a seizure-free 
state, but substantial improvement in seizure control, 
altertness and behaviour. 
SURGICAL TREATMENT 
There may be reluctance at some epilepsy surgery 
centres to assess people with learning disabilities and 
refractory epilepsy. This is due to the view that those 
most at risk of cognitive deterioration after surgery 
are over 55 years of age or with an IQ below 70”‘. 
Another viewpoint has been taken by Silfvenius102 
who has argued that learning disabilities (IQ < 70) 
in a child should not be considered a contradiction 
for paediatric epilepsy surgery as ‘it may amelio- 
rate socially disturbing seizures or distressing be- 
haviour’. Potential surgical intervention should in- 
clude corpus callosum section in patients with learn- 
ing disabilities and generalized seizures or frequent 
daily drop attacks. Although not necessarily curative, 
surgery can result in a higher quality of life*‘, lo23 ‘03. 
Kotagal and Rothner2’ believe that, until evidence to 
the contrary is available, patients with tuberous scle- 
rosis should not be denied epilepsy surgery. In their 
experience, those with a stable seizure focus could 
benefit from resective surgery, even if tubers were 
present in other locations; this was confirmed by Be- 
bin et al. lo4. Surgical approaches are also possible in 
the Sturge-Weber syndrome2’, the Lennox-Gastaut 
syndrome, and infantile spasms (West syndrome)“*. 
With appropriate surgery, children with conditions 
such as hemimegaloencephaly and other diffuse cor- 
ticodysplasias, Sturge-Weber syndrome, large poren- 
cephalic cysts, and Rasmussen’s encephalitis, which 
are associated with inevitable developmental delay, 
have a 60-80% chance of leading a nearly normal 
life and avoiding institutional care’t”. It makes sense, 
therefore, to identify early those patients with leam- 
ing disabilities and epilepsy who might benefit from 
resective surgery. 
PROGNOSIS 
The outlook for many people with learning disabil- 
ities and epilepsy is not as bad as has been be- 
lieved previously, but it does vary according to un- 
derlying and concomitant conditions. After a 12- 
year follow-up period in one study, 39% of children 
with learning disabilities and/or abnormal neurology 
were seizure free, compared with 79% of those with 
epilepsy alone4’. Alvarez64 discontinued antiepileptic 
drug treatment in 50 patients with learning disabili- 
ties, who had been seizure free for at least 2 years. 
After 8 years, the recurrence rate was 52%. Predictors 
for seizure freedom without treatment were few doc- 
umented seizures in a lifetime, no gross neurological 
abnormalities, drug concentrations below target lev- 
els at time of discontinuance, and persistently normal 
EEG s before and after discontinuation of therapy. 
This study should encourage others to modify their 
approach to care in seizure-free patient. 
Concomitant conditions strongly influence the risk 
of seizure recurrence. Brodtkorb47 found that people 
with learning disabilities who developed epilepsy in 
adult life usually were well controlled, particularly 
if there was no history of cerebral palsy. Conversely, 
poorly controlled epilepsy and cerebral palsy were as- 
sociated with early-onset seizures. Another study ex- 
amined the risk of seizure recurrence in children with 
cerebral palsy who had been seizure free for 2 years. 
Patients with spastic hemiparesis had the highest re- 
lapse rate (61.5%) and those with spastic diplegia the 
lowest ( 14.3%)‘Os. 
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CURRENT APPROACHES TO CARE 
People with learning disabilities in the U.K. cur- 
rently under-use health servicesto despite the com- 
mon occurrence of conditions such as epilepsy, cere- 
bral palsy, congenital heart disease, musculoskeletal 
problems and obesity in this populationto7. In ad- 
dition, 50% of those affected have a single sensory 
loss and 18% have twolo*. Understandably, the De- 
partment of Health has called for improved access 
to health promotion, education and surveillance, and 
to primary and secondary care for people with learn- 
ing disabilities’05. Following the publication of the 
Command Document Better Services for the Mentally 
Handicapped in 197 1 lo9 more learning disabled in- 
dividuals have been integrated into or remained in 
community settings rather than being cared for in in- 
stitutional environments. In the U.K. health provision 
for the majority of people with learning disabilities 
comes through community teams and primary care. 
In Wales for example, between 1987 and 1996, the 
number of people with learning disabilities resident in 
hospital fell by 58%. Community learning-disability 
nurses dealt with 55% more people in 1995-1996 
than in 1991-1992’10. 
Primary Care for People with a Mental Handicap 
offers recommendations on care to general practition- 
ers, as they may have little knowledge of, or experi- 
ence in, treating people with learning disabilities de- 
spite an increasing requirement to do so4. Concern 
has been raised about this” ’ and postgraduate train- 
ing has been suggested5. Particular management dif- 
ficulties arise in individuals with dual disability112, 
an example of this, of course, being epilepsy. Al- 
though some general practitioners and other health 
professionals are involved in health surveillance and 
promotion for the learning disabled, most oppose this 
kind of activity due to current lack of evidence of 
resulting benefit’ 13. However such activities can pro- 
vide the ideal opportunity to carry out an epilepsy 
review. This would overcome the criticism that only 
a minority of individuals with learning disabilities and 
epilepsy had any regular assessment of their anticon- 
vulsant drugs. 
The majority of people with epilepsy prefer to re- 
ceive their care in general practice’ 14. In 90% of cases 
in one study, there was no hospital specialist input’ 15. 
In response to this, general practitioners are showing 
greater interest in epilepsy, its treatment and the im- 
plications of the diagnosis”4, r16, 12’. It is hoped that 
a ‘knock-on’ effect in the care of people with learning 
disabilities and epilepsy will follow as this population 
has been largely excluded from primary-care studies. 
Unfortunately problems in epilepsy care at pri- 
mary and secondary levels’22 continue to exist as do 
calls for comprehensive epilepsy services, with ade- 
quate specialist input 6, 123. Secondary-care provision 
including inpatient assessment and long-term care for 
patients with learning disabilities and epilepsy varies 
widely. Such individuals may be referred to centres 
of excellence or to centres with no expertise in the 
fields of learning disability and/or epilepsy. Knowl- 
edge of and experience with the mushrooming num- 
ber of antiepileptic drugs now available are essential. 
‘Mixed’ clinics and wards offering services to people 
with or without learning disabilities can pose prob- 
lems. Busy clinics and a reliance on ambulances can 
result in long waiting times, which can be particularly 
distressing for patients with learning disabilities. Due 
to the stigmas attached to both learning disabilities 
and epilepsy, other patients may feel threatened by 
the presence of the learning disabled. 
An increasing asset to all is the Registered Nurse in 
Mental Handicap (RNMH) as an epilepsy specialist 
nurse, both within hospital settings and in the com- 
munity due to their dual qualification and training124. 
Such nurses liaise with individuals with learning dis- 
abilities and epilepsy, their carers, health profession- 
als and other agencies. They provide information and 
education, and can offer training in the use of rec- 
tal diazepam. In general, nurse specialists are re- 
garded as an effective means of tackling shortcomings 
in epilepsy management122, 125, 126. Indeed, they have 
‘outscored’ general practitioners and hospital special- 
ists across all aspects of treatment and care127. Sadly, 
there is a great lack of community learning disability 
nurses who can also be regarded as epilepsy special- 
ists. 
Psychologists are increasingly becoming involved 
clinically and on a research basis with patients with 
learning disabilities and epilepsyt2*. They are par- 
ticularly well qualified to distinguish between be- 
havioural activity and seizures, especially with the 
advent of video telemetry54. In addition they are at 
the forefront in developing measures to assess the 
impact of epilepsy and its treatment on individuals 
with learning disabilities and their carers’“*. Cur- 
rently available measures relate to seizures, drugs, 
cognitive function, behaviour, social functioning, at- 
titudes, motivation and ‘quality of life’. 
FUTURE APPROACHES TO CARE 
Care provision for people with learning disabilities 
and epilepsy should be based on the general model 
described in the document Specification for Epilepsy 
Services2. The aims for patients with learning disabil- 
ities are the same as those for people with epilepsy 
alone, i.e. achieving maximum health gain, reducing 
morbidity and preventing avoidable mortality. Mor- 
bidity can be decreased by controlling seizures, by re- 
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ducing seizure-related injury, and by providing effec- 
tive support. Due to the variety of concomitant con- 
ditions and specific problems presenting in an indi- 
vidual with learning disabilities, adaptations to tradi- 
tional approaches to care may be necessary with close 
collaboration among different health disciplines129. 
A specialist opinion should be sought for any 
learning disabled person with suspected or proven 
epilepsy. Particular attention should be paid to those 
with uncontrollable epilepsy, those who have been 
seizure free for at least 2 years and who may benefit 
from a reduction or withdrawal of antiepileptic med- 
ication, and those in whom there is concern about 
drug toxicity or unnecessary polypharmacy. Prior to 
an initial hospital appointment, much information can 
be gleaned from a home assessment carried out by a 
learning disability epilepsy specialist nurse following 
an agreed protocol. This protocol should cover not 
only the description of events or behavioural patterns 
suspected to be seizures, but an indication of the in- 
dividual’s IQ, concomitant condition, all medication, 
difficulties in administration and side-effects of drugs, 
antiepileptic drug assay, information about support 
networks, and the individual’s and carer’s particular 
concerns. A vital area is establishing the existence 
of sensory loss and the best method of communica- 
tion. The learning disability nurse, if suitably trained, 
can show carers how best to record behavioural pat- 
terns thought to be seizures, and begin the initial 
information provision and educational process. Gen- 
eral support of family members is important due to 
the impact of chronic epilepsy on levels of stress, 
feelings of dissatisfaction with social situations, per- 
ceived low levels of support, poor emotional adjust- 
ment and depression’“u. 
Prior to the first hospital appointment, all the infor- 
mation obtained should be discussed with the hospital 
specialist and, if appropriate, electroencephalography, 
video recordings and brain imaging arranged. The aim 
is to obtain the maximum amount of information in 
the simplest and most efficient way with the least pos- 
sible disruption and inconvenience to the patient and 
carers. This will allow the hospital specialist to make 
appropriate management decisions when the patient 
first attends the clinic, and may even negate the need 
for subsequent clinic attendances. 
At the outset, following a review of the diagno- 
sis and drug therapy, it is important to formulate a 
management plan and set realistic objectives. Num- 
bers and doses of antiepileptic drugs should be ra- 
tionalized. The projected outcome should be planned 
involving assessment of seizure severity and num- 
bers and, in addition, the likely effects of the seizures 
and their treatment on behaviour and mood. Par- 
ticular emphasis should be placed on sleep pattern, 
appetite, communication, cooperation, and alertness. 
Specific questions on positive or negative changes in 
the patient’s quality of life will often yield impor- 
tant information. In keeping with ‘An epilepsy needs 
document’ 3, the majority of secondary care referrals 
should be discharged back to the general practitioners 
within 12 months. 
General practitioners are known to value the in- 
put of community teams in the care of their patients 
with learning disabilities . ‘I3 Together they can de- 
velop epilepsy review procedures that would reduce 
the need for hospital attendance, be more convenient 
to patients and result in more effective use of health- 
service resources . 13’ Evaluation of such procedures* 
would address potential concerns about their value 
in terms of benefit to the individual or in terms of 
cost”3. General practitioners would be more likely 
to participate in the development and running of 
epilepsy treatment programmes if new or reallocated 
resources were made available to fund them’**, 126. It 
is not clear why epilepsy care is not targeted in the 
same way as diabetes within primary care with gen- 
eral practitioners receiving specific incentives to par- 
ticipate. Chronic disease clinics are generally run by 
the practice nurse, who could undergo specific train- 
ing led by the learning disability specialist nurse. Par- 
ticular clinical problems would then be passed onto 
the general practitioner and/or the community leam- 
ing disability epilepsy specialist nurse. 
Education and training for all staff involved in car- 
ing for people with learning disabilities and epilepsy 
is essential with encouragement to ‘network’ with 
others working in the same areas. Those in contact 
with people with learning disabilities and epilepsy 
should be fully aware of the facilities and special- 
ists available within their own locality. Cooperation 
among such groups optimizes the chance of effective 
care provision, adequate staff training and improving 
local facilities to meet the many needs of the learning 
disabled population. 
CONCLUSION 
The time is right to look afresh at the management of 
people with learning disabilities and epilepsy. The 
cohesive link between the affected individual and 
everyone providing care is the community learning 
disability epilepsy nurse. Such specialist nurses can 
liaise with a wide range of individuals, and their ed- 
ucation and training puts them in a good position to 
coordinate care in this clinical setting. The use of 
standardized assessment and investigation techniques 
will improve the accuracy of diagnosis. A greater 
awareness of the benefits of restricting polypharmacy 
has led to a more positive approach toward reduc- 
ing treatment. This in turn has resulted in less drug 
10 J. A. Hannah & M. J. Brodie 
toxicity. There is now a wider choice of antiepileptic 
drugs, with easier dosage regimens and fewer side- 
effects. Surgery is an increasingly useful option for 
people with learning disabilities. Outcome measures 
currently available and in development will allow a 
clearer understanding of the effects of epilepsy and 
its treatment on patients and their carers. Increasing 
interest in this field is bubbling up world-wide, but 
there is a great need for better communication and 
cooperation to avoid the repetition of mistakes and 
to allow the wider adoption of successful methods of 
assessment and pharmacological strategies. 
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